Suchergebnisse - "Garzon, Simone"

PubPharm (6)

1

Not all stage I and II endometrial cancers are created equal : Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer

enthalten in: Gynecologic oncology | 2022

von Garzon, S. | Grassi, T. | Mariani, A. | +9

2

Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer

enthalten in: Pathology oncology research : POR | 2020

von Benati, M. | Montagnana, M. | Danese, E. | +10

3

PET-CT scan in the preoperative workup of early stage intermediate- and high-risk endometrial cancer

enthalten in: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy | 2020

von Franchi, M. | Garzon, S. | Zorzato, P. | +5

4

Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer

enthalten in: Pathology & oncology research | 2020

von Benati, M. | Montagnana, M. | Danese, E. | +10

5

Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer

enthalten in: Pathology oncology research | 2020

von Benati, M. | Montagnana, M. | Danese, E. | +10

6

Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer

enthalten in: Pathology & oncology research | 2020

von Benati, M. | Montagnana, M. | Danese, E. | +10

1
[1]